The Impact of Schizophrenia and Intelligence on the Relationship Between Age and Brain Volume

Overview

Journal Schizophr Res Cogn

Specialty Psychology

Date 2018 Oct 11

PMID 30302317

Citations 6

Authors

Maria H Jensen

Nikolaj Bak

Egill Rostrup

Mette O Nielsen

Christos Pantelis

Birte Y Glenthoj

Bjorn H Ebdrup

Birgitte Fagerlund

Affiliations

Soon will be listed here.

Abstract

Age has been shown to have an impact on both grey (GM) and white matter (WM) volume, with a steeper slope of age-related decline in schizophrenia compared to healthy controls. In schizophrenia, the relation between age and brain volume is further complicated by factors such as lower intelligence, antipsychotic medication, and cannabis use, all of which have been shown to have independent effects on brain volume. In a study of first-episode, antipsychotic-naïve schizophrenia patients (N = 54) and healthy controls (N = 56), we examined the effects of age on whole brain measures of GM and WM volume, and whether these relationships were moderated by schizophrenia and intelligence (IQ). Secondarily, we examined lifetime cannabis use as a moderator of the relationship between age and brain volume. Schizophrenia patients had lower GM volumes than healthy controls but did not differ on WM volume. We found an age effect on GM indicating that increasing age was associated with lower GM volumes, which did not differ between groups. IQ did not have a direct effect on GM, but showed a trend-level interaction with age, suggesting a greater impact of age with lower IQ. There were no age effects on WM volume, but a direct effect of IQ, with higher IQ showing an association with larger WM volume. Lifetime cannabis use did not alter these findings significantly. This study points to effects of schizophrenia on GM early in the illness, before antipsychotic treatment is initiated, suggesting that WM changes may occur later in the disease process.

Citing Articles

Brain volumes, cognitive, and adaptive skills in school-age children with Down syndrome.

Grzadzinski R, Mata K, Bhatt A, Jatkar A, Garic D, Shen M J Neurodev Disord. 2024; 16(1):70.

PMID: 39701965 PMC: 11660842. DOI: 10.1186/s11689-024-09581-6.

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia.

Mohamed Saini S, Bousman C, Mancuso S, Cropley V, Van Rheenen T, Lenroot R Schizophrenia (Heidelb). 2023; 9(1):59.

PMID: 37709784 PMC: 10502098. DOI: 10.1038/s41537-023-00381-w.

Of differing methods, disputed estimates and discordant interpretations: the meta-analytical multiverse of brain volume and IQ associations.

Pietschnig J, Gerdesmann D, Zeiler M, Voracek M R Soc Open Sci. 2022; 9(5):211621.

PMID: 35573038 PMC: 9096623. DOI: 10.1098/rsos.211621.

A Systematic Review of Cognition-Brain Morphology Relationships on the Schizophrenia-Bipolar Disorder Spectrum.

Karantonis J, Carruthers S, Rossell S, Pantelis C, Hughes M, Wannan C Schizophr Bull. 2021; 47(6):1557-1600.

PMID: 34097043 PMC: 8530395. DOI: 10.1093/schbul/sbab054.

Significant association between intracranial volume and verbal intellectual abilities in patients with schizophrenia and a history of birth asphyxia.

Wortinger L, Jorgensen K, Barth C, Nerland S, Smelror R, Vaskinn A Psychol Med. 2021; :1-10.

PMID: 33750510 PMC: 9772907. DOI: 10.1017/S0033291721000489.

References

Brouwer R, Hedman A, van Haren N, Schnack H, Brans R, Smit D . Heritability of brain volume change and its relation to intelligence. Neuroimage. 2014; 100:676-83. DOI: 10.1016/j.neuroimage.2014.04.072. View

Ebdrup B, Raghava J, Nielsen M, Rostrup E, Glenthoj B . Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade. J Psychiatry Neurosci. 2015; 41(2):133-41. PMC: 4764482. DOI: 10.1503/jpn.150030. View

Ritchie S, Booth T, Valdes Hernandez M, Corley J, Munoz Maniega S, Gow A . Beyond a bigger brain: Multivariable structural brain imaging and intelligence. Intelligence. 2015; 51:47-56. PMC: 4518535. DOI: 10.1016/j.intell.2015.05.001. View

Vita A, De Peri L, DEste G, Sacchetti E . Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012; 2:e190. PMC: 3565772. DOI: 10.1038/tp.2012.116. View

van Haren N, Cahn W, Hulshoff Pol H, Kahn R . Schizophrenia as a progressive brain disease. Eur Psychiatry. 2008; 23(4):245-54. DOI: 10.1016/j.eurpsy.2007.10.013. View

Bak N, Ebdrup B, Oranje B, Fagerlund B, Jensen M, During S . Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology. Transl Psychiatry. 2017; 7(4):e1087. PMC: 5416700. DOI: 10.1038/tp.2017.59. View

Andreasen N, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho B . Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry. 2011; 70(7):672-9. PMC: 3496792. DOI: 10.1016/j.biopsych.2011.05.017. View

Solowij N, Walterfang M, Lubman D, Whittle S, Lorenzetti V, Styner M . Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr Res. 2012; 143(1):179-84. DOI: 10.1016/j.schres.2012.10.040. View

Leucht S, Kane J, Kissling W, Hamann J, Etschel E, Engel R . What does the PANSS mean?. Schizophr Res. 2005; 79(2-3):231-8. DOI: 10.1016/j.schres.2005.04.008. View

10.

Hulshoff Pol H, Schnack H, Bertens M, van Haren N, van der Tweel I, Staal W . Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry. 2002; 159(2):244-50. DOI: 10.1176/appi.ajp.159.2.244. View

11.

Axelrod B . Validity of the Wechsler abbreviated scale of intelligence and other very short forms of estimating intellectual functioning. Assessment. 2002; 9(1):17-23. DOI: 10.1177/1073191102009001003. View

12.

Cropley V, Klauser P, Lenroot R, Bruggemann J, Sundram S, Bousman C . Accelerated Gray and White Matter Deterioration With Age in Schizophrenia. Am J Psychiatry. 2016; 174(3):286-295. DOI: 10.1176/appi.ajp.2016.16050610. View

13.

Hedman A, van Haren N, Schnack H, Kahn R, Hulshoff Pol H . Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies. Hum Brain Mapp. 2011; 33(8):1987-2002. PMC: 6870052. DOI: 10.1002/hbm.21334. View

14.

Zalesky A, Solowij N, Yucel M, Lubman D, Takagi M, Harding I . Effect of long-term cannabis use on axonal fibre connectivity. Brain. 2012; 135(Pt 7):2245-55. DOI: 10.1093/brain/aws136. View

15.

Haijma S, van Haren N, Cahn W, Koolschijn P, Hulshoff Pol H, Kahn R . Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2012; 39(5):1129-38. PMC: 3756785. DOI: 10.1093/schbul/sbs118. View

16.

Shaw P, Greenstein D, Lerch J, Clasen L, Lenroot R, Gogtay N . Intellectual ability and cortical development in children and adolescents. Nature. 2006; 440(7084):676-9. DOI: 10.1038/nature04513. View

17.

Van Haren N, Cahn W, Hulshoff Pol H, Kahn R . Confounders of excessive brain volume loss in schizophrenia. Neurosci Biobehav Rev. 2012; 37(10 Pt 1):2418-23. DOI: 10.1016/j.neubiorev.2012.09.006. View

18.

Sun D, Stuart G, Jenkinson M, Wood S, McGorry P, Velakoulis D . Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry. 2008; 14(10):976-86. PMC: 2773126. DOI: 10.1038/mp.2008.34. View

19.

Mesholam-Gately R, Giuliano A, Goff K, Faraone S, Seidman L . Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009; 23(3):315-36. DOI: 10.1037/a0014708. View

20.

Pietschnig J, Penke L, Wicherts J, Zeiler M, Voracek M . Meta-analysis of associations between human brain volume and intelligence differences: How strong are they and what do they mean?. Neurosci Biobehav Rev. 2015; 57:411-32. DOI: 10.1016/j.neubiorev.2015.09.017. View